The table below shows CATALYST PHARMACEUTICALS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q2 2022
Q1 2022
Operating cash flow
$59.59M
$60.04M
$31.93M
$12.07M
-
$8.48M
Capital expenditure
$27.00K
$0.00
$199.00K
$74.00K
-
-
Investing cash flow
-$27.00K
$0.00
-$199.00K
-$162.37M
-
-
Dividends paid
-
-
-
-
-
-
CPRX operating cash flow (10-K history)
CATALYST PHARMACEUTICALS, INC. reported operating cash flow of $208.67M for fiscal year 2025. That is down 13.0% from $239.81M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$9.88M (FY 2013) to $208.67M. Figures come from the company's audited annual reports as filed with the SEC.
